Association of aspirin dose and vorapaxar safety and efficacy in patients with non-st-segment elevation acute coronary syndrome (from the tracer trial)

American Journal of Cardiology

Volumn 113, Issue 6, 2014, Pages 936-944

  Mahaffey, Kenneth W ^a   Huang, Zhen ^b   Wallentin, Lars ^c   Storey, Robert F ^d   Jennings, Lisa K ^e,f   Tricoci, Pierluigi ^b   White, Harvey D ^g   Armstrong, Paul W ^h   Aylward, Philip E ⁱ   Moliterno, David J ^j   Van De Werf, Frans ^k   Chen, Edmond ^l   Leonardi, Sergio ^b,m   Rorick, Tyrus ^b   Held, Claes ^c   Strony, John ⁿ   Harrington, Robert A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f CirQuest Labs LLC   (United States)

^g AUCKLAND CITY HOSPITAL   (New Zealand)

^h UNIVERSITY OF ALBERTA   (Canada)

ⁱ FLINDERS UNIVERSITY   (Australia)

^j UNIVERSITY OF KENTUCKY   (United States)

^k UNIVERSITY OF LEUVEN   (Belgium)

^l Bayer HealthCare Pharmaceuticals Inc   (United States)

^m FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

ⁿ MERCK RESEARCH LABORATORIES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO; VORAPAXAR;

ADULT; AGED; ARTICLE; BLEEDING; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVASCULARIZATION; RISK FACTOR; RISK REDUCTION; TREATMENT OUTCOME; UNITED STATES; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ADMINISTRATION, ORAL; AGED; ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LACTONES; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PYRIDINES; RECEPTORS, THROMBIN; TREATMENT OUTCOME;

EID: 84896732051     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.11.052     Document Type: Article

References (10)

1. P. Tricoci, Z. Huang, C. Held, D.J. Moliterno, P.W. Armstrong, F. Van de Werf, H.D. White, P.E. Aylward, L. Wallentin, E. Chen, Y. Lokhnygina, J. Pei, S. Leonardi, T.L. Rorick, A.M. Kilian, L.H. Jennings, G. Ambrosio, C. Bode, A. Cequier, J.H. Cornel, R. Diaz, A. Erkan, K. Huber, M.P. Hudson, L. Jiang, J.W. Jukema, B.S. Lewis, A.M. Lincoff, G. Montalescot, J.C. Nicolau, H. Ogawa, M. Pfisterer, J.C. Prieto, W. Ruzyllo, P.R. Sinnaeve, R.F. Storey, M. Valgimigli, D.J. Whellan, P. Widimsky, J. Strony, R.A. Harrington, K.W. Mahaffey, and TRACER Investigators Thrombin-receptor antagonist vorapaxar in acute coronary syndromes N Engl J Med 366 2012 20 33
2. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
3. 2012 Writing Committee Members, H. Jneid, J.L. Anderson, R.S. Wright, C.D. Adams, C.R. Bridges, D.E. Casey Jr., S.M. Ettinger, F.M. Fesmire, T.G. Ganiats, A.M. Lincoff, E.D. Peterson, G.J. Philippides, P. Theroux, N.K. Wenger, J.P. Zidar, J.L. Anderson, American College of Cardiology Foundation American Heart Association Task Force on Practice Guidelines 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 126 2012 875 910
4. C.W. Hamm, J.P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, P. Caso, D. Dudek, S. Gielen, K. Huber, M. Ohman, M.C. Petrie, F. Sonntag, M.S. Uva, R.F. Storey, W. Wijns, D. Zahger, and ESC Committee for Practice Guidelines ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2999 3054
5. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K.W. Mahaffey, B.M. Scirica, A. Skene, P.G. Steg, R.F. Storey, R.A. Harrington, PLATO Investigators, A. Freij, and M. Thorsén Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
6. K.W. Mahaffey, D.M. Wojdyla, K. Carroll, R.C. Becker, R.F. Storey, D.J. Angiolillo, C. Held, C.P. Cannon, S. James, K.S. Pieper, J. Horrow, R.A. Harrington, L. Wallentin PLATO Investigators Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial Circulation 124 2011 544 554
7. TRACER Executive and Steering Committees The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale Am Heart J 158 2009 327 334
8. J.L. Mega, E. Braunwald, S.D. Wiviott, J.P. Bassand, D.L. Bhatt, C. Bode, P. Burton, M. Cohen, N. Cook-Bruns, K.A. Fox, S. Goto, S.A. Murphy, A.N. Plotnikov, D. Schneider, X. Sun, F.W. Verheugt, C.M. Gibson ATLAS ACS 2-TIMI 51 Investigators Rivaroxaban in patients with a recent acute coronary syndrome N Engl J Med 366 2012 9 19
9. J.H. Alexander, R.D. Lopes, S. James, R. Kilaru, Y. He, P. Mohan, D.L. Bhatt, S. Goodman, F.W. Verheugt, M. Flather, K. Huber, D. Liaw, S.E. Husted, J. Lopez-Sendon, R. De Caterina, P. Jansky, H. Darius, D. Vinereanu, J.H. Cornel, F. Cools, D. Atar, J.L. Leiva-Pons, M. Keltai, H. Ogawa, P. Pais, A. Parkhomenko, W. Ruzyllo, R. Diaz, H. White, M. Ruda, M. Geraldes, J. Lawrence, R.A. Harrington, L. Wallentin APPRAISE-2 Investigators Apixaban with antiplatelet therapy after acute coronary syndrome N Engl J Med 365 2011 699 708
10. W.J. Dewilde, T. Oirbans, F.W. Verheugt, J.C. Kelder, B.J. De Smet, J.P. Herrman, T. Adriaenssens, M. Vrolix, A.A. Heestermans, M.M. Vis, J.G. Tijsen, A.W. van 't Hof, J.M. ten Berg WOEST study investigators Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial Lancet 381 2013 1107 1115